Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 mars 2024 14h58 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare...
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
29 févr. 2024 09h54 HE
|
PRISM MarketView
PRISM MarketView Highlights Work of Emerging Companies on Rare Disease Day
Community Leaders Unite to Provide Support and Resources for Thousands of Utahns with Rare Diseases
21 févr. 2023 11h00 HE
|
Recursion Pharmaceuticals
Salt Lake City, Utah, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rare Disease advocacy organizations and biotech and healthcare industry leaders will partner to accelerate the diagnosis and improve the care...
Caelum Biosciences Announces Collaborations with the Amyloidosis Advocacy Community and Support of Amyloidosis Awareness Month
01 mars 2021 08h00 HE
|
Caelum Biosciences, Inc.
BORDENTOWN, N.J., March 01, 2021 (GLOBE NEWSWIRE) -- Caelum Biosciences, Inc. (“Caelum”), a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases, today...
Mustang Bio Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
26 févr. 2021 08h00 HE
|
Mustang Bio, Inc.
WORCESTER, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in...
Fortress Biotech Joins Global Movement to Raise Awareness for Rare Diseases and Supports Rare Disease Day®
26 févr. 2021 08h00 HE
|
Fortress Biotech, Inc.
NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative revenue-generating company focused on acquiring, developing and commercializing or...
Retrophin Recognizes Rare Disease Day 2020 and the Importance of Working Together Toward More Equitable Access to Care
28 févr. 2020 08h00 HE
|
Retrophin, Inc.
SAN DIEGO, Feb. 28, 2020 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) will join the National Organization for Rare Disorders (NORD), the European Organisation for Rare Diseases (EURORDIS), and...
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day
28 févr. 2019 10h38 HE
|
Delcath Systems, Inc.
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver,...
Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day®
28 févr. 2019 09h00 HE
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today the Company is joining forces with the nearly 30 million...
GeneDx Joins Rare Disease Organizations to Support Rare Disease Day 2019
28 févr. 2019 08h00 HE
|
GeneDx
GAITHERSBURG, Md., Feb. 28, 2019 (GLOBE NEWSWIRE) -- GeneDx, Inc., a subsidiary of OPKO Health, Inc.’s BioReference Laboratories, Inc. and recognized leader in genetic testing, joins the worldwide...